Wagner, Florence F.

Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories

Gräff, J., Joseph, N. F., Horn, M. E., Samiei, A., Meng, J., Seo, J., Rei, D., Bero, A. W., Phan, T. X., Wagner, F., et al. (2014) · Cell

Memory and Neural MechanismsMemory Processes and Influences

Cited by 357

Hdac3 is essential for the maintenance of chromatin structure and genome stability

Bhaskara, S., Knutson, S. K., Jiang, G., Chandrasekharan, M. B., Wilson, A. J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J.-L., Bonine-Summers, A. R., et al. (2010) · Cancer Cell

Histone Deacetylase Inhibitors ResearchGenomics and Chromatin Dynamics

Cited by 353

Progress in Understanding and Treating SCN2A-Mediated Disorders

Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences

Epilepsy research and treatmentIon channel regulation and function

Cited by 338

A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests

Schroeder, F. A., Lewis, M. C., Fass, D. M., Wagner, F. F., Zhang, Y.-L., Hennig, K. M., Gale, J., Zhao, W.-N., Reis, S., Barker, D. D., et al. (2013) · PLoS ONE

Histone Deacetylase Inhibitors ResearchTreatment of Major Depression

Cited by 146

Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers

Wagner, F. F., Zhang, Y.-L., Fass, D. M., Joseph, N., Gale, J. P., Weïwer, M., McCarren, P., Fisher, S. L., Kaya, T., Zhao, W.-N., et al. (2015) · Chemical Science

Histone Deacetylase Inhibitors ResearchCholinesterase and Neurodegenerative Diseases

Cited by 104

Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists

Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling

Nerve injury and regenerationPharmacological Receptor Mechanisms and Effects

Cited by 94

An Isochemogenic set of inhibitors to define the therapeutic potential of histone deacetylases in β-cell protection

Wagner, F. F., Lundh, M., Kaya, T., McCarren, P., Zhang, Y.-L., Chattopadhyay, S., Gale, J. P., Galbo, T., Fisher, S. L., Meier, B. C., et al. (2016) · ACS Chemical Biology

Histone Deacetylase Inhibitors ResearchEnzyme function and inhibition

Cited by 86

Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection

Barton, K. M., Archin, N. M., Keedy, K. S., Espeseth, A. S., Zhang, Y.-L., Gale, J., Wagner, F. F., Holson, E. B., & Margolis, D. M. (2014) · PLoS ONE

HIV Research and TreatmentHistone Deacetylase Inhibitors Research

Cited by 76

Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6

Porter, N. J., Wagner, F. F., & Christianson, D. W. (2018) · Biochemistry

Histone Deacetylase Inhibitors ResearchEnzyme function and inhibition

Cited by 64